Pancreatic Cancer Research

ResearcherNational Institutes of HealthNo recent work listed

Kevin A. Camphausen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0450-4877; OpenAlex author ID A5036663495. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: none · 2016: 1 paper

Papers 2

  1. A phase I trial of cabozantinib and gemcitabine in advanced pancreatic cancer. Co-author DOI 10.1007/s10637-016-0376-1↗
  2. EGFR isoforms in exosomes as a novel method for biomarker discovery in pancreatic cancer. First author DOI 10.2217/bmm.11.80↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Edward Jae-Hoon Kim · 1 shared paper, 2016 · strength 0.06
  2. Diane M. Simeone · 1 shared paper, 2016 · strength 0.06
  3. Mark M. Zalupski · 1 shared paper, 2016 · strength 0.06
  4. David Bing Zhen · 1 shared paper, 2016 · strength 0.06
  5. Vaibhav Sahai · 1 shared paper, 2016 · strength 0.06
  6. William Tristram Arscott · 1 shared paper, 2011 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.